An open, randomized, phase IIIa study to evaluate the safety and immunogenicity of GSK Biologicals' 10-valent pneumococcal conjugate vaccine, when administered intramuscularly according to a 2-4-11 months vaccination schedule
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Infections, Streptococcal
Phase 3
A follow on study 111736 was conducted. An annotated case report form is not available for this study. A blank case report form will be provided.
September 2013